Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers

• Published in: PloS one 2015-12, Vol.10 (12), p.e0144380-e0144380
• Main Authors: Inic-Kanada, Aleksandra, Stojanovic, Marijana, Schlacher, Simone, Stein, Elisabeth, Belij-Rammerstorfer, Sandra, Marinkovic, Emilija, Lukic, Ivana, Montanaro, Jacqueline, Schuerer, Nadine, Bintner, Nora, Kovacevic-Jovanovic, Vesna, Krnjaja, Ognjen, Mayr, Ulrike Beate, Lubitz, Werner, Barisani-Asenbauer, Talin
• Format: Article
• Language: English
• Subjects: Adhesins, Bacterial - immunology; Amino acids; Animals; Antigens; Bacteria; Bacterial vaccines; Blindness; Blotting, Western; Carriers; Cell Proliferation; Chlamydia; Chlamydia trachomatis; Chlamydia trachomatis - immunology; Chlamydiae; Conjunctiva; Conjunctiva - immunology; Disease Models, Animal; Drug Carriers - chemistry; Drug delivery systems; E coli; Epitopes; Escherichia coli - metabolism; Eye - immunology; Eye - microbiology; Eye - pathology; Female; Genetic aspects; Ghosts; Guinea Pigs; Immune response; Immune response (cell-mediated); Immune response (humoral); Immune system; Immunization; Immunoglobulin A; Immunoglobulin A - metabolism; Immunoglobulin G - blood; Immunology; Infections; Inflammation; Injections, Subcutaneous; Interferon-gamma - metabolism; Interleukin-4 - metabolism; Membrane proteins; Mice; Mice, Inbred BALB C; Mucosa; Mucous Membrane - immunology; Mucous Membrane - microbiology; Mucous Membrane - pathology; Particulate Matter - chemistry; Particulates; Physiological aspects; Prevention; Probiotics; Protein C; Proteins; R&D; Recombinant Proteins - metabolism; Research & development; Sexually transmitted diseases; Spleen - pathology; STD; Tears; Tears - metabolism; Trachoma; Trachoma - immunology; Trachoma - microbiology; Trachoma - pathology; Trachoma - prevention & control; Vaccines; Vaccines, Subunit - immunology; Virology; γ-Interferon
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0144380

Trachoma, caused by the intracellular bacterium Chlamydia trachomatis (Ct), remains the world's leading preventable infectious cause of blindness. Recent attempts to develop effective vaccines rely on modified chlamydial antigen delivery platforms. As the mechanisms engaged in the pathology of the disease are not fully understood, designing a subunit vaccine specific to chlamydial antigens could improve safety for human use. We propose the delivery of chlamydia-specific antigens to the ocular mucosa using particulate carriers, bacterial ghosts (BGs). We therefore characterized humoral and cellular immune responses after conjunctival and subcutaneous immunization with a N-terminal portion (amino acid 1-893) of the chlamydial polymorphic membrane protein C (PmpC) of Ct serovar B, expressed in probiotic Escherichia coli Nissle 1917 bacterial ghosts (EcN BGs) in BALB/c mice. Three immunizations were performed at two-week intervals, and the immune responses were evaluated two weeks after the final immunization in mice. In a guinea pig model of ocular infection animals were immunized in the same manner as the mice, and protection against challenge was assessed two weeks after the last immunization. N-PmpC was successfully expressed within BGs and delivery to the ocular mucosa was well tolerated without signs of inflammation. N-PmpC-specific mucosal IgA levels in tears yielded significantly increased levels in the group immunized via the conjunctiva compared with the subcutaneously immunized mice. Immunization with N-PmpC EcN BGs via both immunization routes prompted the establishment of an N-PmpC-specific IFNγ immune response. Immunization via the conjunctiva resulted in a decrease in intensity of the transitional inflammatory reaction in conjunctiva of challenged guinea pigs compared with subcutaneously and non-immunized animals. The delivery of the chlamydial subunit vaccine to the ocular mucosa using a particulate carrier, such as BGs, induced both humoral and cellular immune responses. Further investigations are needed to improve the immunization scheme and dosage.